2-(2-Chloropyridin-4-yl)propan-2-ol, 98%, 1g

3-amino-3-oxopropanoic acid, 95.0%, 250mg

N-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide, 95.0%, 10g

2-(4-(2-Bromobenzyl)piperazin-1-yl)ethan-1-ol, 98%, 250mg

[1,1'-Biphenyl]-2,2',4,4',6,6'-hexacarboxylic acid, 97%, 100mg

Methyl 5-(4-bromophenyl)isoxazole-3-carboxylate, 95.0%, 5g

5-chloro-4H-1,2,4-triazol-3-amine hydrochloride, 95+%, 1g

5-(Methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid, 95.0%, 500g

5-bromo-N-(2-methoxyethyl)-2-furamide, 95.0%, 1g

3-Chlorobenzonitrile, 98.0%, 10g

Éthylène glycol, min 98 %, tech., 25 l, emballage plastique.

Ethyl 2-(adamantan-1-ylamino)-2-oxoacetate, 98%, 2g

1-((4-Bromophenyl)sulfonyl)pyrrolidine, 98%, 1g